Archive for September 2017

“A champion named Goliath…came out from the Philistine camp. He was over nine feet tall. He had a bronze helmet on his head and wore a coat of scale armor of bronze weighing [125 pounds]; on his legs he wore bronze greaves, and a bronze javelin was slung on his back. His spear shaft was like a…

Let’s do a quick word association exercise. What is the first word that comes to mind when you read each of the terms below? Trial Investigator Subject Attrition Arms Targets Chances are your responses were somehow affected by your level of familiarity with medicines development. Introduction Patients are the most important stakeholders in the development of…

Introduction Patients are the most important stakeholders in the development of new therapies. Thus, one might conclude that patients must be involved in the process of developing these therapies. While there are some excellent examples of patient involvement improving both the execution and the focus of clinical trials, it is far from the norm.[1] Why? It is only over…